Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001235179 | SCV001407854 | uncertain significance | Brugada syndrome 8 | 2021-05-13 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C25". The leucine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with HCN4-related conditions. This variant is present in population databases (rs776635828, ExAC 0.002%). This sequence change replaces valine with leucine at codon 772 of the HCN4 protein (p.Val772Leu). The valine residue is highly conserved and there is a small physicochemical difference between valine and leucine. |